EUVIMEDEUVIMED entdecken
Open Access

Prior Exposure to Azithromycin and Azithromycin Resistance Among Persons Diagnosed With Neisseria gonorrhoeae Infection at a Sexual Health Clinic: 2012–2019

Emily Rowlinson iD, Olusegun O Soge, James P Hughes iD, Anna Berzkalns, Christina Thibault, Roxanne P Kerani, Christine M Khosropour, Lisa E Manhart, Matthew R Golden, Lindley A Barbee

Clinical Infectious Diseases · 08.02.2023 · 76 (3) · e1270-e1276

DOI: 10.1093/cid/ciac682 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 24.08.2022. Verfasst von Emily Rowlinson und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Gonorrhea, Sexual Health. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCATS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is conflicting evidence on whether prior azithromycin (AZM) exposure is associated with reduced susceptibility to AZM (AZMRS) among persons infected with Neisseria gonorrhoeae (NG).

Methods

The study population included Public Health–Seattle and King County Sexual Health Clinic (SHC) patients with culture-positive NG infection at ≥1 anatomic site whose isolates were tested for AZM susceptibility in 2012–2019. We used multivariate logistic regression to examine the association of time since last AZM prescription from the SHC in ≤12 months with subsequent diagnosis with AZMRS NG (minimum inhibitory concentration [MIC], ≥2.0 µg/mL) and used linear regression to assess the association between the number of AZM prescriptions in ≤12 months and AZM MIC level, controlling for demographic, behavioral, and clinical characteristics.

Results

A total of 2155 unique patients had 2828 incident NG infections, 156 (6%) of which were caused by AZMRS NG. AZMRS NG was strongly associated with receipt of AZM from the SHC in the prior 29 days (adjusted odds ratio, 6.76; 95% confidence interval [CI], 1.76 to 25.90) but not with receipt of AZM in the prior 30–365 days. Log AZM MIC level was not associated with the number of AZM prescriptions within ≤12 months (adjusted correlation, 0.0004; 95% CI, –.04 to .037) but was associated with number of prescriptions within <30 days (adjusted coefficient, 0.56; 95% CI, .13 to .98).

Conclusions

Recent individual-level AZM treatment is associated with subsequent AZMRS gonococcal infections. The long half-life and persistence of subtherapeutic levels of AZM may result in selection of resistant NG strains in persons with recent AZM use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GonorrheaSexual HealthHumansAzithromycinAnti-Bacterial AgentsDrug Resistance, BacterialNeisseria gonorrhoeaeMicrobial Sensitivity TestsCeftriaxone

Stichwörter der Autor:innen

Neisseria gonorrhoeaeantimicrobial resistanceazithromycintreatment

Substanzen

AzithromycinAnti-Bacterial AgentsCeftriaxone

Autor:innen und Institutionen

  • Department of Epidemiology, University of Washington, Seattle, Washington, USA.
  • Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA.
  • Neisseria Reference Laboratory, University of Washington, Seattle, Washington, USA.
  • Department of Global Health, University of Washington, Seattle, Washington, USA.
  • Department of Biostatistics, University of Washington, Seattle, Washington, USA.
  • HIV/STD Program, Public Health-Seattle and King County, Seattle, Washington, USA.

ORCID-Profile: Emily Rowlinson, James P Hughes

Förderung

  • NIAID NIH HHS
  • NCATS NIH HHS
  • National Institutes of Health
  • CDC

Zitieren

APA

Rowlinson, E., Soge, O. O., Hughes, J. P., Berzkalns, A., Thibault, C., Kerani, R. P., Khosropour, C. M., Manhart, L. E., Golden, M. R., & Barbee, L. A. (2023). Prior Exposure to Azithromycin and Azithromycin Resistance Among Persons Diagnosed With Neisseria gonorrhoeae Infection at a Sexual Health Clinic: 2012–2019. Clinical Infectious Diseases, 76(3), e1270-e1276. https://doi.org/10.1093/cid/ciac682

Vancouver

Rowlinson E, Soge OO, Hughes JP, Berzkalns A, Thibault C, Kerani RP, et al. Prior Exposure to Azithromycin and Azithromycin Resistance Among Persons Diagnosed With Neisseria gonorrhoeae Infection at a Sexual Health Clinic: 2012–2019. Clinical Infectious Diseases. 2023;76(3):e1270-e1276. doi:10.1093/cid/ciac682

BibTeX
@article{Rowlinson2023,
  author = {Rowlinson, Emily and Soge, Olusegun O and Hughes, James P and Berzkalns, Anna and Thibault, Christina and Kerani, Roxanne P and Khosropour, Christine M and Manhart, Lisa E and Golden, Matthew R and Barbee, Lindley A},
  title = {Prior Exposure to Azithromycin and Azithromycin Resistance Among Persons Diagnosed With Neisseria gonorrhoeae Infection at a Sexual Health Clinic: 2012–2019},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {76},
  number = {3},
  pages = {e1270--e1276},
  doi = {10.1093/cid/ciac682}
}
Kostenlos starten →